AUA 2018: Selection of Appropriate Genitourinary Cancers for ImmunotherapyUroTodayHe highlighted FDA approved indications for immunotherapy in genitourinary oncology, including for urothelial carcinoma and clear cell renal cell carcinoma. Additionally,… Continue reading
AUA 2018: Selection of Appropriate Genitourinary Cancers for ImmunotherapyUroTodayHe highlighted FDA approved indications for immunotherapy in genitourinary oncology, including for urothelial carcinoma and clear cell renal cell carcinoma. Additionally,… Continue reading
News-Medical.netGene therapy that reverses blindness in dogs could also help treat humansNews-Medical.netA Michigan State University veterinary ophthalmologist has modified a gene therapy that reverses blindness in dogs that have a certain form of a di… Continue reading
Seeking Alpha |
3 Things In Biotech, May 19: Buy BMY? Oncolytics In Again? Atara’s Immunotherapy Data
Seeking Alpha Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we’re talking about! Here is some more information if you’re curious. Welcome to another edition of “3 Things In … |